Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

What you keep posting assumes uses that are theoretical and have little to no evidence of efficacy in even animals because 1) Prurisol will likely require reformulation even if the current form does show promise; 2) Abacavir and the current salt of abacavir was formulated against psoriasis and not other inflammatory diseases like arthritis; and 3) assumes things not even publicly discussed as uses and plans by IPIX scientists.

While there is an argument that Prurisol currently has a valuation ranging from 500 to 1000 million at the current stage, $10 billion to nearly everyone is premature, considered highly excessive and an attempt to pump the price, all of which result in exactly the opposite of the post’s and valuation’s intent.